Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse
About this trial
Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.
Eligibility criteria
Qualifiers
Adult
Patient living at home or in an institution
Patient hospitalized for less than 48 hours
respiratory functional symptoms (cough, sputum, dyspnea, chest pain) and
Disqualifiers
Pneumonia acquired at the hospital.
Patient hospitalized in another department more than 48 hours before admission
Chronic respiratory failure
Active neoplasia
Trial design
Treatments tested in this trial
- O2 automated
- O2 standard
Treatment groups
128 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov